NVTA
Price:
$0.019
Market Cap:
$5.44M
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, Califor...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-02-12
Stock Exchange
NYSE
Ticker
NVTA
According to Invitae Corporation’s latest financial reports and current stock price. The company's current ROE is 472.72%. This represents a change of 206.92% compared to the average of 154.02% of the last 4 quarters.
The mean historical ROE of Invitae Corporation over the last ten years is -338.14%. The current 472.72% ROE has changed -239.80% with respect to the historical average. Over the past ten years (40 quarters), NVTA's ROE was at its highest in in the March 2023 quarter at 524.29%. The ROE was at its lowest in in the June 2022 quarter at -653.91%.
Average
-338.14%
Median
-64.31%
Minimum
-3050.29%
Maximum
66.63%
Discovering the peaks and valleys of Invitae Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 23.87%
Maximum Annual ROE = 66.63%
Minimum Annual Increase = -214.00%
Minimum Annual ROE = -3050.29%
Year | ROE | Change |
---|---|---|
2022 | -3050.29% | 23.87% |
2021 | -12.73% | -58.84% |
2020 | -30.91% | -51.50% |
2019 | -63.74% | -20.26% |
2018 | -79.93% | -21.10% |
2017 | -101.30% | 0.11% |
2016 | -101.19% | 55.96% |
2015 | -64.88% | -214.00% |
2014 | 56.92% | -14.57% |
2013 | 66.63% | -1.18% |
The current ROE of Invitae Corporation (NVTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1031.31%
5-year avg
-647.52%
10-year avg
-338.14%
Invitae Corporation’s ROE is greater than CRISPR Therapeutics AG (-13.85%), greater than Pacific Biosciences of California, Inc. (-61.44%), greater than Intellia Therapeutics, Inc. (-49.70%), greater than Editas Medicine, Inc. (-62.61%), greater than Twist Bioscience Corporation (-38.91%),
Company | ROE | Market cap |
---|---|---|
-13.85% | $3.80B | |
-61.44% | $430.60M | |
-49.70% | $2.00B | |
-62.61% | $296.09M | |
-38.91% | $2.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Invitae Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Invitae Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Invitae Corporation's ROE?
How is the ROE calculated for Invitae Corporation (NVTA)?
What is the highest ROE for Invitae Corporation (NVTA)?
What is the 3-year average ROE for Invitae Corporation (NVTA)?
What is the 5-year average ROE for Invitae Corporation (NVTA)?
How does the current ROE for Invitae Corporation (NVTA) compare to its historical average?